Table 5.
Characteristics of those adherent to surveillance at 1-yr intervals vs no endoscopic follow up n (%)
| Measures | 1-yr surveillance (n = 12) | No post-discharge EGD (n = 46) | P value |
| Male | 7 (58) | 29 (63) | 0.7518 |
| Age, median (range), yr | 55 (45-78) | 54.5 (31-82) | 0.4237 |
| Etiology of cirrhosis, | |||
| Alcohol | 6 (50) | 28 (61) | 0.5273 |
| Hepatitis C | 2 (17) | 6 (13) | 0.6649 |
| Other | 4 (33) | 12 (26) | 0.7200 |
| Recent alcohol use | 4 (33) | 21 (46) | 0.5255 |
| Distance from hospital, median (range), kilometers | 30.4 (3.7-80.3) | 20.9 (1.5-95.1) | 0.4965 |
| MELD score, median (range) | 11.5 (6-17) | 13 (7-26) | 0.1707 |
| Child-turcotte-pugh classification | |||
| A | 3 (25) | 9 (20) | 0.6983 |
| B | 6 (50) | 27 (59) | 0.7455 |
| C | 3 (25) | 10 (21) | 1.0000 |
| Index bleed in 2007 or earlier | 2 (17) | 19 (41) | 0.1790 |
| Medicaid1 or uninsured | 0 (0) | 17 (37) | 0.0119 |
| Comorbid psychiatric disorder | 5 (42) | 19 (41) | 1.0000 |
| Length of stay, median (range), d | 6 (3-7) | 5 (3-75) | 0.6455 |
| Beta-blocker at discharge | 12 (100) | 38 (80) | 0.1851 |
1
Government-sponsored health plan that assists with medical costs in selected low income individuals. MELD: Model for end-stage liver disease; EGD: Esophagogastroduodenoscopy.